MyMD Phase 2 Study Hits Key Goals in Age-Related Frailty MYMD

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
  
By Colin Kellaher MyMD Pharmaceuticals on Monday reported positive topline results from a Phase 2 study of its lead product candidate in patients with...

Read at marketwatch.com
marketwatch News
  

MYMD Old Fundamental Analysis

We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

MYMD Old is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

MYMD Old Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.

Peers

MYMD Old Related Equities

UBXUnity Biotechnology   34.59   
0%
100.0%
NBYNovaBay Pharmaceuticals   9.37   
0%
27.0%
PASGPassage Bio   1.52   
0%
4.0%
GOVXGeoVax Labs   1.36   
0%
3.0%
KZRKezar Life   1.06   
3.0%
0%
AVIRAtea Pharmaceuticals   2.10   
6.0%
0%
KROSKeros Therapeutics   2.22   
6.0%
0%
KRONKronos Bio   3.03   
8.0%
0%
LRMRLarimar Therapeutics   3.43   
9.0%
0%
LGNDLigand Pharmaceuticals   3.89   
11.0%
0%
REPLReplimune   4.08   
11.0%
0%
RXRXRecursion Pharmaceuticals   5.23   
15.0%
0%
BOLTBolt Biotherapeutics   5.26   
15.0%
0%
XBIOXenetic Biosciences   5.39   
15.0%
0%
NVCTNuvectis Pharma   5.83   
16.0%
0%
ORICOric Pharmaceuticals   6.35   
18.0%
0%
GOSSGossamer Bio   7.62   
22.0%
0%
LYELLyell Immunopharma   7.69   
22.0%
0%
REVBRevelation Biosciences   8.62   
24.0%
0%
LYRALyra Therapeutics   9.09   
26.0%
0%
DSGNDesign Therapeutics   11.02   
31.0%
0%
SRZNSurrozen   12.96   
37.0%
0%
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in MYMD Stock

If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios